News

Kadmon will co-promote the product through its sales force and extensive network of specialty pharmacies. Financial terms of the agreement were not disclosed. Kadmon chairman and CEO Samuel

This patent describes a method for the chemical synthesis of the A3 adenosine receptor agonist, IB-MECA, which is the active pharmaceuticals ingredient (API) of the CF101 drug candidate.

The private label shake which is currently shipping, carries the Muscle Maker Grill ’42’ moniker. It comes in three great tasting flavors – Vanilla, Chocolate and Strawberry –

Recently, DKSH Business Unit Consumer Goods, Asia’s leading market expansion services provider for fast moving consumer goods, and Henkel’s Laundry and Home Care business entered into a long-term

Myalept, an analogue of leptin made through recombinant DNA technology, is the first and only treatment approved by the FDA for these patients. The company is currently working

Gevokizumab is a potent monoclonal antibody with an allosteric modulating properties and the potential to treat patients with a variety of inflammatory and other diseases. It binds strongly

The new JV will produce and dispense legal medical cannabis to Health Canada patients in British Columbia. CanMED expects to complete the licensing process in the next few

Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from submission, with a target action date of

As part of the deal, Ardelyx would also be eligible to get royalties on product sales as well as retain an option to participate in co-promotional activities for